Results suggested that PIK3CD expression were higher in the circulation (p = 0.0453) (Fig. 7a) and TGF-β2 had no observable changes (Fig. 7b) in breast cancer patients when compared to normal control. Here, PIK3CD is linked to breast carcinoma.